Novartis's Ianalumab Meets Goals in Phase 3 Trials to Treat Primary Immune Thrombocytopenia Novartis said its ianalumab drug combined with eltrombopag met the primary endpoint in a late-stage trial, ...

Seven West Media, which generates the most of its earnings through Seven Network's free-to-air TV and broadcast video on demand units, offers exposure to the AUD 3.3 billion total Australian linear ...